Thermo Fisher Scientific Inc (NYSE:TMO) VP Seth H. Hoogasian sold 4,140 shares of the stock in a transaction on Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the sale, the vice president now directly owns 25,518 shares of the company’s stock, valued at approximately $4,537,100.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at 182.95 on Thursday. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $183.32. The firm has a market capitalization of $71.37 billion, a price-to-earnings ratio of 31.87 and a beta of 1.06. The firm’s 50-day moving average is $176.80 and its 200 day moving average is $167.41.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter last year, the firm posted $2.03 EPS. The company’s quarterly revenue was up 10.2% on a year-over-year basis. Analysts forecast that Thermo Fisher Scientific Inc will post $9.33 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.45%.

TRADEMARK VIOLATION WARNING: “Seth H. Hoogasian Sells 4,140 Shares of Thermo Fisher Scientific Inc (TMO) Stock” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.watchlistnews.com/seth-h-hoogasian-sells-4140-shares-of-thermo-fisher-scientific-inc-tmo-stock/1533129.html.

Several large investors have recently bought and sold shares of the company. Huntington National Bank increased its stake in Thermo Fisher Scientific by 6.9% in the first quarter. Huntington National Bank now owns 186,907 shares of the medical research company’s stock worth $28,708,000 after buying an additional 12,025 shares in the last quarter. Rothschild Investment Corp IL increased its stake in Thermo Fisher Scientific by 114.0% in the first quarter. Rothschild Investment Corp IL now owns 70,732 shares of the medical research company’s stock worth $10,864,000 after buying an additional 37,675 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in Thermo Fisher Scientific during the first quarter worth $468,000. Hermes Investment Management Ltd. increased its stake in Thermo Fisher Scientific by 6.1% in the first quarter. Hermes Investment Management Ltd. now owns 631,129 shares of the medical research company’s stock worth $96,941,000 after buying an additional 36,367 shares in the last quarter. Finally, Retirement Systems of Alabama increased its stake in Thermo Fisher Scientific by 0.6% in the first quarter. Retirement Systems of Alabama now owns 258,308 shares of the medical research company’s stock worth $39,676,000 after buying an additional 1,477 shares in the last quarter. 83.52% of the stock is owned by institutional investors.

Several research firms have recently issued reports on TMO. Bank of America Corporation reissued a “buy” rating and issued a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Barclays PLC reissued an “overweight” rating and issued a $200.00 price objective (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Wells Fargo & Co reissued an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. Finally, Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price objective for the company in a research report on Tuesday, July 11th. One equities research analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $188.56.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.